Contact the publisher of this press release
Inviragen and Pharmajet Receive $15.5 Million NIAID Contract to Develop a Needle-Free Dengue Vaccine
Inviragen and Pharmajet Receive $15.5 Million NIAID Contract to Develop a Needle-Free Dengue Vaccine